Ensuring healthy lives and promoting well-being for all at all ages, as envisioned by Sustainable Development Goal 3 (SDG 3), is a profound challenge that necessitates a multifaceted approach, transcending traditional boundaries and silos. The inextricable link between health, economic productivity, and societal prosperity underscores the pivotal role of public economics in realizing this ambitious objective.

The pursuit of universal health coverage (UHC) is a cornerstone of SDG 3, with far-reaching implications for public financing and resource allocation mechanisms. Achieving UHC requires robust and equitable health financing systems that strike a delicate balance between efficiency, affordability, and quality. Public economics offers invaluable insights into the design and implementation of such systems, encompassing revenue generation strategies, risk-pooling mechanisms, and strategic purchasing arrangements.

Taxation policies play a pivotal role in mobilizing domestic resources for health expenditures while simultaneously influencing health-related behaviors and outcomes. Excise taxes on tobacco, alcohol, and unhealthy foods can serve as powerful tools for curbing consumption, generating revenue for health initiatives, and offsetting the substantial economic burden imposed by non-communicable diseases. However, the optimal design and implementation of such taxes necessitate a nuanced understanding of consumer behavior, market dynamics, and distributional impacts across socioeconomic strata.

Moreover, the global health workforce crisis, exacerbated by the COVID-19 pandemic, underscores the need for innovative public-private partnerships and incentive structures to attract and retain skilled healthcare professionals, particularly in underserved areas. Public economics can shed light on the intricate interplay between labor market forces, compensation structures, and non-pecuniary incentives, informing policies that foster a sustainable and equitably distributed health workforce.

Ensuring access to affordable and essential medicines is another critical aspect of SDG 3, with profound implications for public procurement, intellectual property rights, and market regulation. Public economics offers valuable insights into pricing mechanisms, market failures, and strategic interventions to balance innovation incentives and affordability imperatives, fostering an ecosystem that promotes both pharmaceutical innovation and equitable access.

Furthermore, the growing recognition of the complex interconnections between health, environmental determinants, and climate change underscores the need for a comprehensive, systems-level approach. Public economics can inform policies that incentivize sustainable production and consumption patterns, facilitate the transition towards renewable energy sources, and foster resilient and climate-adaptive health systems.

Ultimately, achieving SDG 3 demands a holistic and evidence-based approach that harmonizes economic, social, and environmental considerations. Public economics, with its interdisciplinary lens and rigorous analytical frameworks, is well-positioned to navigate the intricate trade-offs and synergies that arise in the pursuit of universal health coverage, sustainable financing mechanisms, and intersectoral collaboration for health promotion and disease prevention.

As we collectively strive towards the ambitious targets of SDG 3, public economics can illuminate pathways for mobilizing resources, optimizing resource allocation, and aligning incentives across diverse stakeholders. By leveraging the powerful tools of public economics, policymakers can craft innovative and context-specific strategies that not only improve health outcomes but also contribute to broader societal goals of equity, sustainability, and inclusive economic growth.


